# language_name_wals:	English
# language_name_glotto:	English
# iso639_3:	eng
# year_composed:	NA
# year_published:	NA
# mode:	written
# genre_broad:	technical
# genre_narrow:	NA
# writing_system:	Latn
# special_characters:	NA
# short_description:	EMEA
# source:	https://object.pouta.csc.fi/OPUS-EMEA/v3/raw/en.zip
# copyright_short:	http://opus.nlpl.eu/EMEA.php
# copyright_long:	http://opus.nlpl.eu/EMEA.php J. Tiedemann, 2012, Parallel Data, Tools and Interfaces in OPUS. In Proceedings of the 8th International Conference on Language Resources and Evaluation (LREC 2012)
# sample_type:	whole
# comments:	NA

EU Number
Invented name
Strength
Pharmaceutical Form
Route of Administration
Packaging
Content
Package size
EU/ 1/ 06/ 357/ 001
Gardasil
--1
Suspension for injection
Intramuscular use
vial (glass)
0.5 ml
1 vial
EU/ 1/ 06/ 357/ 002
Gardasil
--1
Suspension for injection
Intramuscular use
vial (glass)
0.5 ml
10 vials
EU/ 1/ 06/ 357/ 003
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
1 pre-filled syringe
EU/ 1/ 06/ 357/ 004
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
10 pre-filled syringes
EU/ 1/ 06/ 357/ 005
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
1 pre-filled syringe + 1 needle
EU/ 1/ 06/ 357/ 006
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
10 pre-filled syringes + 10 needles
EU/ 1/ 06/ 357/ 007
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
1 pre-filled syringe + 2 needles
EU/ 1/ 06/ 357/ 008
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
10 pre-filled syringes + 20 needles
EU/ 1/ 06/ 357/ 009
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
1 pre-filled syringe with needle guard
EU/ 1/ 06/ 357/ 010
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
10 pre-filled syringes with needle guard
EU/ 1/ 06/ 357/ 011
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
20 pre-filled syringes with needle guard
EU/ 1/ 06/ 357/ 012
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
1 pre-filled syringe with needle guard + 1 needle
EU/ 1/ 06/ 357/ 013
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
10 pre-filled syringes with needle guard + 10 needles
EU/ 1/ 06/ 357/ 014
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
20 pre-filled syringes with needle guard + 20 needles
EU/ 1/ 06/ 357/ 015
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
1 pre-filled syringe with needle guard + 2 needles
EU/ 1/ 06/ 357/ 016
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
10 pre-filled syringes with needle guard + 20 needles
1/ 2 EU/ 1/ 06/ 357/ 017
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
20 pre-filled syringes with needle guard + 40 needles
EU/ 1/ 06/ 357/ 018
Gardasil
--1
Suspension for injection
Intramuscular use
vial (glass)
0.5 ml
20 vials
EU/ 1/ 06/ 357/ 019
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
20 pre-filled syringes
EU/ 1/ 06/ 357/ 020
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
20 pre-filled syringes + 20 needles
EU/ 1/ 06/ 357/ 021 1
Gardasil
--1
Suspension for injection
Intramuscular use
pre-filled syringe (glass)
0.5 ml
20 pre-filled syringe + 40 needles
1 dose (0.5 ml) contains
approximately:
Human Papillomavirus¹ Type 6 L1 protein², ³ Human Papillomavirus¹ Type 11 L1 protein², ³ Human Papillomavirus¹ Type 16 L1 protein², ³ Human Papillomavirus¹ Type 18 L1 protein², ³
20 micrograms 40 micrograms 40 micrograms 20 micrograms
¹ Human Papillomavirus = HPV
² L1 protein in the form of virus-like particles produced in yeast cells (Saccharomyces cerevisiae CANADE 3C-5 (Strain 1895)) by recombinant DNA technology ³ adsorbed on amorphous aluminium hydroxyphosphate sulphate adjuvant (225 micrograms Al)
2/ 2